Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination of a purine-based CDK inhibitor with a tyrosine kinase inhibitor and use thereof in the treatment of proliferative disorders

Combination of a purine-based CDK inhibitor with a tyrosine kinase inhibitor and use thereof in the treatment of proliferative disorders

US Patent 9173938 · Granted Nov 3, 2015

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Extending a software defined network between public cloud computing architecture2024
Functionalized nucleic acid nanostructures for RNA delivery2022
Cyanoindoline derivatives as NIK inhibitors2021
Substituted cyanoindoline derivatives as NIK inhibitors2021
Heteroaromatic derivatives as NIK inhibitors2021
6-membered heteroaromatic substituted cyanoindoline derivatives as NIK inhibitor2021
Dosage regimen for sapacitabine and seliciclib2018
Method for producing a solder joint2015
Combinations of sapacitabine or CNDAC with DNA methyltransferase inhibitors such2015
Combinations of sapacitabine or CNDAC with DNA methyltransferase inhibitors such2015
Trisubstituted purine derivatives2013
Trisubstituted purine derivatives2013